Private Label Tranexamic Acid Body Butter Manufacturer

MOQs for private label tranexamic acid body butter typically fall into two tiers based on whether you choose a stock formula or a fully custom formula. For stock or white-label programs — where the manufacturer already has a validated TXA body butter base and you are adding your brand name, label, and sometimes fragrance — MOQs commonly run 50 to 250 units per SKU. These lower thresholds exist because the manufacturer has already absorbed the development and stability-testing costs. For custom formulas — where you specify a unique active combination (for example, tranexamic acid plus niacinamide plus a specific botanical extract), a proprietary texture, or a fully bespoke fragrance — MOQs typically start at 100 to 500 units and can reach 1,000 units at larger contract manufacturers. The higher floor reflects the cost of lab time, prototype iterations, and dedicated stability testing. Several factors push MOQs in either direction. Jar size matters: a 4 oz body butter jar running at 50 units produces only about 12.5 lbs of bulk, which is too small for many filling lines to run economically. Moving to 100 units at the same fill weight doubles the batch and often unlocks better pricing. Packaging complexity also moves the needle — custom-printed jars or metallic labels typically add a packaging MOQ of their own, forcing the total unit count up to 250 or 500 even if the filler would take 100. The concentration of tranexamic acid also matters. Manufacturers who compound TXA as a custom active blend may require you to purchase a minimum raw-material lot — sometimes 1 kg — which, at a 3% use level in a 250 g jar, equates to roughly 133 units before you even consider the base and packaging. Understanding this math before you negotiate saves time. First-time founders sometimes mistake a low MOQ for an indication that quality is lower. That is not accurate — several ISO 22716-certified contract manufacturers in the US, UK, and South Korea specialize in small-batch actives-forward formulas. The key is vetting GMP credentials regardless of MOQ. AJ Cosmo Labs lists manufacturers with their MOQ, so you can review suppliers that match your unit needs directly inside the app without guesswork.

Cost for private label tranexamic acid body butter breaks into four main buckets: formulation and development, raw materials, fill and finish (manufacturing), and packaging. Formulation and development costs range from $0 for stock-formula white-label programs (where no new development work is needed) to $500–$3,000 for a fully custom brief that requires the cosmetic chemist to develop and iterate a new base, optimize TXA solubility, and run stability testing. Some manufacturers bundle a one-time setup fee of $250–$800 instead of charging separately for lab time. This fee is usually waived or credited toward production once you hit a target order size. Raw material costs for a tranexamic acid body butter are driven primarily by the active itself and the butter blend. Pharmaceutical-grade tranexamic acid costs approximately $25–$60 per kilogram at cosmetic sourcing quantities, so at a 3% use level in a 250 g jar, the TXA alone contributes roughly $0.20–$0.45 per unit. Shea butter, mango butter, and complementary emollients add another $0.50–$1.50 per unit depending on whether the specification calls for organic, fair-trade, or conventional sourcing. Fill and finish (the act of manufacturing, filling, sealing, and labeling) typically costs $1.50–$5.00 per unit at low-MOQ quantities (50–500 units) and drops to $0.80–$2.50 per unit at scale (2,500+ units). Whipped textures that require aeration add a small premium over press-and-fill anhydrous butters. Packaging — the jar, lid, inner seal, outer label, and optional box — adds $0.80–$3.00 per unit depending on material choice and decoration method. Frosted glass jars with custom embossing sit at the top of that range; plain PET jars with a paper label sit at the bottom. All-in, a finished private label tranexamic acid body butter typically costs $4–$12 per unit at low-MOQ runs. At the $4 end you are working with a stock formula in a simple jar at 100+ units. At $12 you have a custom formula, organic certified butters, an airless pump, and foil-stamped labeling. A standard retail keystone markup (2–2.5×) puts your launch retail price in the $10–$30 range, which aligns well with current market positioning for the category. To get accurate quotes from multiple vetted manufacturers side by side, post your product brief on AJ Cosmo Labs and let suppliers compete on price and terms.

Tranexamic acid is permitted for use in cosmetics in both the United States and the European Union, but the regulatory framing differs meaningfully between the two regions. In the United States, the FDA does not regulate cosmetic ingredients through a pre-market approval system (with the exception of color additives). Tranexamic acid is not on the FDA's prohibited or restricted ingredient list, so it may be used in cosmetic formulations without prior approval. However, the claims you make about the product determine whether it is regulated as a cosmetic or an OTC drug. Claims that reference physiological activity — such as "inhibits melanin production" or "skin-lightening" — may trigger the FDA's OTC drug monograph framework. Most US brands position TXA products using cosmetic-compliant language such as "visibly brightens uneven skin tone" or "reduces the appearance of dark spots" to stay firmly in cosmetic territory. There is currently no formal OTC drug monograph for TXA-based skin-lightening products in the US, which means products making drug-level lightening claims would be considered unapproved new drugs. In the European Union, cosmetic ingredients are regulated under Regulation (EC) No. 1223/2009. Tranexamic acid is not listed in Annex II (prohibited substances) or Annex III (restricted substances) as of the time of writing, meaning it may be used as a cosmetic active without restriction. However, an EU-responsible person must commission a Cosmetic Product Safety Report (CPSR) from a qualified safety assessor before placing any TXA-containing product on the EU market. The CPSR must confirm that the concentration of TXA used is safe for the intended route of exposure (topical, leave-on, body butter). For the UK post-Brexit, the UK Cosmetics Regulation (retained EU law, SI 2019/696) applies substantially the same rules as the EU framework. A UK responsible person and a UK CPSR are required for products sold in Great Britain. In South Korea, one of the largest markets for brightening actives, tranexamic acid is classified as a "functional cosmetic" ingredient when used for skin brightening, and the product must be registered with the Ministry of Food and Drug Safety (MFDS) before sale. This is a meaningful additional step compared to US or EU requirements. A common first-timer mistake is assuming that because TXA is not on a banned list, no regulatory homework is needed. The claim review, INCI labeling accuracy, and stability data requirements still apply in every market. Your manufacturer should provide the INCI name (Tranexamic Acid) in the correct descending order on the label, and your compliance review should happen before, not after, production.

Total lead time for a private label tranexamic acid body butter runs 6–14 weeks from the moment you submit a complete product brief to the moment finished goods ship. The range is wide because several variables can compress or extend individual phases. Weeks 1–2 cover the initial product brief, formula selection or custom development kickoff, and signing of the non-disclosure and co-manufacturing agreements. If you choose a stock formula from the manufacturer's existing library, this phase can close in a single week. If you are building a custom formula — specifying TXA percentage, co-actives, scent, and texture — the cosmetic chemist needs time to develop an initial lab batch, which typically takes 1–2 additional weeks. Weeks 2–4 cover prototype review. The manufacturer sends lab-scale samples (usually 1–3 jars) for your evaluation of color, skin feel, melt point, and fragrance. Revisions extend this phase; founders who give clear, specific feedback on the first round typically move through in one iteration. Vague feedback — "make it less greasy" without context — can add 2–4 weeks of back-and-forth. Weeks 4–8 cover stability and safety testing. This is the phase most founders underestimate. Accelerated stability for a body butter runs at 40 °C and 75% relative humidity for a minimum of 4 weeks, with readings at week 0, week 2, and week 4. Some manufacturers run concurrent freeze-thaw cycles. A formula with water content (a water-in-oil emulsion rather than a true anhydrous butter) also requires microbial challenge testing under ISO 11930. If your brief required going back to reformulation after the first stability read, add another 4–6 weeks. Weeks 6–10 are used in parallel for packaging procurement. Custom-printed jars or labels typically require 3–5 weeks of lead time from the packaging supplier. Delays here — a color match rejection, a label artwork revision — are the most common cause of overall project slippage. Weeks 10–14 cover production, QC, and shipment. The manufacturer runs the full batch, fills and seals units, applies labels, performs final batch QC (viscosity, pH where applicable, active assay), and releases the batch. Domestic US manufacturers typically ship within 1–2 weeks of release; overseas manufacturers add 2–4 weeks for sea freight. The fastest path to market is a stock-formula white-label program with in-stock packaging. Some manufacturers can fulfill these in 3–5 weeks total. The AJ Cosmo Labs app lets you filter by "stock formula available" so you can identify those suppliers immediately.

Tranexamic acid is a formulation-friendly active that is compatible with most other brightening and skin-conditioning ingredients, making it an excellent anchor in a multi-active body butter formulation. Niacinamide is the most popular pairing. Niacinamide (vitamin B3) works via a complementary mechanism — it inhibits the transfer of melanosomes from melanocytes to keratinocytes — and is well-tolerated at 2–5% in leave-on body formulas. The combination produces a broadened brightening effect that covers multiple points in the pigmentation pathway, a fact that resonates strongly in marketing copy. Kojic acid is another common co-active, used at 0.5–2% to inhibit tyrosinase directly. It is slightly less stable than TXA in anhydrous butter bases and can discolor (turn pink-brown) when exposed to heat and oxygen, so manufacturers working with this combination often incorporate chelating agents like EDTA and recommend opaque, airtight packaging. Alpha-arbutin (0.5–2%) pairs well with TXA and is considered one of the gentler tyrosinase inhibitors, which makes this combination particularly attractive to brands positioning for sensitive skin or for markets where hydroquinone is restricted. Vitamin C (ascorbic acid) and its stable derivatives (ascorbyl glucoside, sodium ascorbyl phosphate, ascorbyl tetraisopalmitate) are often requested alongside TXA. Stability is the critical consideration: l-ascorbic acid in an anhydrous base can be relatively stable compared to its behavior in water-based serums, but the pH and trace metal management still require careful formulation. Your cosmetic chemist should confirm compatibility before quoting the formula. Azelaic acid at 5–10% is an increasingly popular addition for its dual role in pigmentation and acne, particularly relevant in underarm and body-acne-prone area positioning. It is well-tolerated as a cosmetic active at lower concentrations, though at the therapeutic 15–20% range it crosses into prescription territory in most markets. Hyaluronic acid, panthenol (pro-vitamin B5), and ceramides are common functional supporting actives that improve the moisturization narrative without complicating the brightening story. The biggest formulation mistake founders make is requesting too many high-percentage actives at once without considering the finished formula's elegance and stability. A body butter carrying TXA at 3%, niacinamide at 4%, kojic acid at 1.5%, and vitamin C at 2% simultaneously is both expensive and formulation-complex. An experienced cosmetic chemist will guide you toward a focused two- or three-active combination that is stable, elegant, and costable at your target retail price. You can find cosmetic chemists who specialize in actives-forward skin care briefs through the AJ Cosmo Labs marketplace.

Finding a credible, low-MOQ manufacturer for an actives-forward formula like a tranexamic acid body butter requires more targeted vetting than a generic private label search. The stakes are higher because active-ingredient accuracy, stability, and compliant labeling all depend on manufacturer competence. The first step is building a clear product brief before you contact any manufacturer. This brief should specify: the active (tranexamic acid, percentage target, grade), the base type (anhydrous butter blend vs. water-in-oil emulsion), desired additional actives, fragrance preference (fragrance-free, unscented, or a specific fragrance oil or essential oil blend), target fill weight (common options: 4 oz, 6 oz, 8 oz, 16 oz), jar preference (glass vs. PET, wide-mouth jar vs. airless pump), target MOQ, desired price per unit, and market(s) you intend to sell in. A complete brief produces accurate quotes; an incomplete brief produces ranges so wide they are useless for planning. Second, verify GMP certification. Request a copy of the manufacturer's ISO 22716 certificate or equivalent GMP audit report. Do not accept a verbal assurance. Facilities that are FDA-registered and inspected are an additional mark of credibility for US-market products. Third, ask for evidence of prior experience with actives-forward skin care — specifically, ask whether they have manufactured TXA formulas before and whether they can supply a redacted stability summary or safety data sheet from a comparable formula. A manufacturer who has never worked with TXA will have a steeper onboarding curve and may not be equipped to troubleshoot solubility or stability issues. Fourth, request references or public reviews from other indie brands they manufacture for. Reputable low-MOQ manufacturers often work with dozens of small brands and are happy to provide a reference contact or point to brands publicly using their private label services. Fifth, understand the total cost of switching. Selecting the wrong manufacturer — poor TXA assay accuracy, failed stability, labeling errors — means scrapping an entire batch and restarting the timeline. Front-loading the vetting process is always cheaper than discovering problems at QC release. AJ Cosmo Labs simplifies this process by admin-reviewing manufacturer applications and organizing them by MOQ tier and product category. You can download the AJ Cosmo Labs iPhone app, post your tranexamic acid body butter brief in under five minutes, and begin receiving responses from qualified manufacturers without cold-emailing strangers or paying for a sourcing consultant.

Packaging selection for a tranexamic acid body butter affects product stability, brand perception, and your unit economics simultaneously — so the choice deserves more attention than most first-time founders give it. From a stability standpoint, the primary enemies of a TXA body butter are light, oxygen, and repeated contamination from fingers. Tranexamic acid itself is relatively photostable compared to actives like retinol or vitamin C, but repeated light exposure over a product's 12–24-month shelf life can contribute to gradual degradation. For this reason, opaque jars — white, black, frosted, or colored — are strongly preferred over clear. If aesthetics demand a clear jar, a UV-inhibitor in the resin or an opaque shrink sleeve over the exterior can partially compensate. Airless pump jars offer the best protection for TXA body butters that contain water (water-in-oil emulsions), because they minimize oxygen headspace and eliminate finger-dipping contamination entirely. The trade-off is cost: a 200 ml airless pump jar typically costs $1.20–$2.50 per unit at low-MOQ packaging quantities, compared to $0.40–$0.90 for a comparable wide-mouth jar. The fill process is also more complex, requiring compatibility testing between the pump mechanism and the butter's viscosity. For true anhydrous body butters (no water phase), wide-mouth jars remain the most practical format. They are easy to fill at low MOQ on semi-automated filling lines, easy for consumers to scoop from, and available in a wide range of material options: PET plastic, HDPE, glass, and bamboo-capped options for eco-positioning. The minimum jar size that allows a smooth, even label is typically 60 ml; most body butter launches use 100–250 ml jars for full-body use. Label substrate matters for body-use products. Waterproof or water-resistant label stock (BOPP — biaxially oriented polypropylene) is strongly recommended because body butters are handled in the bathroom where moisture contact is common. A paper label on a body butter jar that sits near a sink will peel within weeks of purchase, which directly affects perceived brand quality and generates returns. Inner seals (foil induction seals or pressure-sensitive seals inside the lid) add tamper evidence and extend shelf life by reducing oxygen exposure. They add approximately $0.05–$0.15 per unit and are worth including if you are selling on Amazon, in retail, or in markets where tamper evidence is expected by consumers. Your manufacturer should confirm that your chosen packaging has been tested with the specific body butter formula — both for compatibility (no migration, no off-gassing from plasticizers, no staining of labels) and for fill compatibility (viscosity range the filling equipment can handle at your chosen temperature). Packaging compatibility testing is part of a complete stability protocol and should never be skipped, even on a low-MOQ launch run.